R. Sebree

Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer.

J. Herman, S. Baylin, M. Brock, 2011, Cancer discovery.

Phase 2 Study of Pemetrexed and Itraconazole as Second-Line Therapy for Metastatic Nonsquamous Non–Small-Cell Lung Cancer

Jun O. Liu, D. Ettinger, C. Rudin, 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Interim analysis of a phase II trial of 5-azacitidine (5AC) and entinostat (SNDX-275) in relapsed advanced lung cancer (NSCLC).

S. Baylin, M. Brock, C. Rudin, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer.

J. Herman, S. Baylin, M. Brock, 2011, Cancer discovery.